These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25559266)

  • 1. Activation of the peroxisome proliferator-activated receptor γ counteracts sepsis-induced T cell cytotoxicity toward alloantigenic target cells.
    von Knethen A; Sha LK; Knape T; Kuchler L; Giegerich AK; Schulz M; Hauser IA; Brüne B
    J Mol Med (Berl); 2015 Jun; 93(6):633-44. PubMed ID: 25559266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitrated fatty acid, 10-nitrooleate inhibits the neutrophil chemotaxis via peroxisome proliferator-activated receptor gamma in CLP-induced sepsis in mice.
    Panati K; Subramani PA; Reddy MM; Derangula M; Arva Tatireddigari VRR; Kolliputi N; Narala VR
    Int Immunopharmacol; 2019 Jul; 72():159-165. PubMed ID: 30981081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor γ-induced T cell apoptosis reduces survival during polymicrobial sepsis.
    Schmidt MV; Paulus P; Kuhn AM; Weigert A; Morbitzer V; Zacharowski K; Kempf VA; Brüne B; von Knethen A
    Am J Respir Crit Care Med; 2011 Jul; 184(1):64-74. PubMed ID: 21471100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis.
    Soller M; Tautenhahn A; Brüne B; Zacharowski K; John S; Link H; von Knethen A
    J Leukoc Biol; 2006 Jan; 79(1):235-43. PubMed ID: 16380602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.
    Li J; Figueira SK; Vrazo AC; Binkowski BF; Butler BL; Tabata Y; Filipovich A; Jordan MB; Risma KA
    J Immunol; 2014 Jul; 193(2):519-28. PubMed ID: 24928990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.
    Getachew Y; Stout-Delgado H; Miller BC; Thiele DL
    J Immunol; 2008 Dec; 181(11):7810-7. PubMed ID: 19017970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M; Ohminami H; Yakushijin Y; Arai J; Hasegawa A; Ishida Y; Fujita S
    J Immunol; 1999 May; 162(10):6100-6. PubMed ID: 10229852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.
    von Knethen A; Schäfer A; Kuchler L; Knape T; Christen U; Hintermann E; Fißlthaler B; Schröder K; Brandes RP; Genz B; Abshagen K; Pützer BM; Sha LK; Weigert A; Syed SN; Schulz M; Shah AM; Ernst A; Putyrski M; Finkelmeier F; Pesic M; Greten F; Hogardt M; Kempf VAJ; Gunne S; Parnham MJ; Brüne B
    Theranostics; 2019; 9(7):2003-2016. PubMed ID: 31037153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS.
    Araújo CV; Campbell C; Gonçalves-de-Albuquerque CF; Molinaro R; Cody MJ; Yost CC; Bozza PT; Zimmerman GA; Weyrich AS; Castro-Faria-Neto HC; Silva AR
    Shock; 2016 Apr; 45(4):393-403. PubMed ID: 26618986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome Proliferator-Activated Receptor δ Suppresses the Cytotoxicity of CD8+ T Cells by Inhibiting RelA DNA-Binding Activity.
    Cen B; Wei J; Wang D; DuBois RN
    Cancer Res Commun; 2024 Oct; 4(10):2673-2684. PubMed ID: 39292167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of epitope-specific antiretroviral cytotoxic T lymphocytes via Fas ligand-Fas interactions.
    Rich RF; Green WR
    Viral Immunol; 2006; 19(3):424-33. PubMed ID: 16987061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting lymphotoxin beta receptor with tumor-specific T lymphocytes for tumor regression.
    Yang D; Ud Din N; Browning DD; Abrams SI; Liu K
    Clin Cancer Res; 2007 Sep; 13(17):5202-10. PubMed ID: 17785576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
    Lin X; Pease LR; Murray PD; Rodriguez M
    J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II.
    Maeda A; Okazaki T; Inoue M; Kitazono T; Yamasaki M; Lemonnier FA; Ozaki S
    Int Immunopharmacol; 2009 Sep; 9(10):1183-8. PubMed ID: 19540938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response.
    Funatake CJ; Ao K; Suzuki T; Murai H; Yamamoto M; Fujii-Kuriyama Y; Kerkvliet NI; Nohara K
    J Immunotoxicol; 2009 Sep; 6(3):194-203. PubMed ID: 19635034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR aggravated CD4
    Zhao G; Xie Y; Lei X; Guo R; Cui N
    Int Immunopharmacol; 2024 Oct; 140():112822. PubMed ID: 39096877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.